REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharmapost, S. R. O. (Slovakia)

Main Activities: Management Consulting Services | Administrative Management and General Management Consulting Services
Full name: Pharmapost, S. R. O. Profile Updated: July 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pharmapost, S. R. O. is a company based in Slovakia, with its head office in Kosice. It operates in the Management Consulting Services sector. It was incorporated on December 01, 2017. There are currently 5 - 9 (2025) people employed by Pharmapost, S. R. O.. The company’s latest financial report indicates a net sales revenue increase of 8.86% in 2024. A growth of 14.9% was recorded in its total assets. The net profit margin of Pharmapost, S. R. O. decreased by 0.45% in 2024.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04001

Contact Details: Purchase the Pharmapost, S. R. O. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmapost, S. R. O. report to view the information.
Registered Capital:
Purchase the Pharmapost, S. R. O. report to view the information.
Financial Auditors:
Purchase the Pharmapost, S. R. O. report to view the information.
Incorporation Date:
December 01, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pharmapost, S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
8.86%▲
Total operating revenue
8.83%▲
Operating profit (EBIT)
-23.82%▼
EBITDA
-16.42%▼
Net Profit (Loss) for the Period
-19.43%▼
Total Assets
14.9%▲
Total Equity
21.58%▲
Operating Profit Margin (ROS)
-0.67%▼
Net Profit Margin
-0.45%▼
Return on Equity (ROE)
-9.04%▼
Debt/Equity
-0.87%▼
Quick Ratio
0.08%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo